This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Practice Guideline

. 2010 May:21 Suppl 5:v93-7.

doi: 10.1093/annonc/mdq222.

Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment

E Van Cutsem¹, B Nordlinger, A Cervantes; ESMO Guidelines Working Group

Affiliations

PMID: 20555112
DOI: 10.1093/annonc/mdq222

Free article

Practice Guideline

Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment

E Van Cutsem et al. Ann Oncol. 2010 May.

Free article

. 2010 May:21 Suppl 5:v93-7.

doi: 10.1093/annonc/mdq222.

Authors

E Van Cutsem¹, B Nordlinger, A Cervantes; ESMO Guidelines Working Group

Affiliation

¹ University Hospital Gasthuisberg, Leuven, Belgium.

PMID: 20555112
DOI: 10.1093/annonc/mdq222

No abstract available

PubMed Disclaimer

Similar articles

Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up.
Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A; ESMO Guidelines Working Group. Labianca R, et al. Ann Oncol. 2010 May;21 Suppl 5:v70-7. doi: 10.1093/annonc/mdq168. Ann Oncol. 2010. PMID: 20555107 No abstract available.
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Haie-Meder C, Morice P, Castiglione M; ESMO Guidelines Working Group. Haie-Meder C, et al. Ann Oncol. 2010 May;21 Suppl 5:v37-40. doi: 10.1093/annonc/mdq162. Ann Oncol. 2010. PMID: 20555099 No abstract available.
Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.
Bellmunt J, Orsola A, Maldonado X, Kataja V; ESMO Guidelines Working Group. Bellmunt J, et al. Ann Oncol. 2010 May;21 Suppl 5:v134-6. doi: 10.1093/annonc/mdq175. Ann Oncol. 2010. PMID: 20555063 No abstract available.
New possibilities in chemotherapy for colorectal cancer.
Bekradda M, Cvitkovic E. Bekradda M, et al. Ann Oncol. 1999;10 Suppl 6:105-11. Ann Oncol. 1999. PMID: 10676561 Review. No abstract available.
Optimal treatment of metastatic colorectal cancer.
Pessino A, Sobrero A. Pessino A, et al. Expert Rev Anticancer Ther. 2006 May;6(5):801-12. doi: 10.1586/14737140.6.5.801. Expert Rev Anticancer Ther. 2006. PMID: 16759170 Review.

See all similar articles

Cited by

Impact of Dose-Escalated Chemoradiation on Pathological Complete Response in Patients with Locally Advanced Rectal Cancer.
Domingo-Boluda C, Dualde D, Taberner-Bonastre T, Soler M, López-Campos F. Domingo-Boluda C, et al. Cancers (Basel). 2024 Sep 16;16(18):3170. doi: 10.3390/cancers16183170. Cancers (Basel). 2024. PMID: 39335142 Free PMC article.
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study.
Schultheis B, Folprecht G, Kuhlmann J, Ehrenberg R, Hacker UT, Köhne CH, Kornacker M, Boix O, Lettieri J, Krauss J, Fischer R, Hamann S, Strumberg D, Mross KB. Schultheis B, et al. Ann Oncol. 2013 Jun;24(6):1560-7. doi: 10.1093/annonc/mdt056. Epub 2013 Mar 13. Ann Oncol. 2013. PMID: 23493136 Free PMC article. Clinical Trial.
Literature Review of Current Management of Colorectal Liver Metastasis.
Mitchell D, Puckett Y, Nguyen QN. Mitchell D, et al. Cureus. 2019 Jan 23;11(1):e3940. doi: 10.7759/cureus.3940. Cureus. 2019. PMID: 30937238 Free PMC article. Review.
Involvement of Both Extrinsic and Intrinsic Apoptotic Pathways in Tridecylpyrrolidine-Diol Derivative-Induced Apoptosis In Vitro.
Nosalova N, Keselakova A, Kello M, Martinkova M, Fabianova D, Pilatova MB. Nosalova N, et al. Int J Mol Sci. 2023 Jul 20;24(14):11696. doi: 10.3390/ijms241411696. Int J Mol Sci. 2023. PMID: 37511455 Free PMC article.
Efficacy and safety of raltitrexed plus S-1 versus regorafenib in patients with refractory metastatic colorectal cancer: a real-world propensity score matching study.
Zhou YW, Wang JL, Li QF, He YL, Li LJ, Liu RZ, Chen Y, Zhang S, Qiu M, Liu JY. Zhou YW, et al. Therap Adv Gastroenterol. 2022 May 18;15:17562848221098246. doi: 10.1177/17562848221098246. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35601804 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information